Log In
Print
BCIQ
Print
Print this Print this
 

cangrelor (formerly AR-C69931MX)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionReversible purinergic receptor P2Y G protein-coupled 12 (P2RY12; P2Y12) antagonist
Molecular Target Purinergic receptor P2Y G protein-coupled 12 (P2RY12) (P2Y12)
Mechanism of ActionPurinergic receptor P2Y G protein-coupled 12 (P2RY12) (P2Y12) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today